GYRE

NASDAQ · Equity

Gyre Therapeutics Inc.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
5.910000
Fair value
10.665365
Expectation
Undecided 54.20%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
5.91
12-Week Change
-21.77%
Trend Signal
Inactive
Expectation
Undecided 54.20%
Signal Weeks
1 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-36.56
Market Dynamics
-1.01

Over the latest 12 completed weeks ending 2026-05-29, GYRE fell 21.77%, moving from 7.55 to 5.91. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -36.56 and has softened across the 12-week window. Market Dynamics is -1.01 on the latest week. Expectation is undecided at 54.20%.